Clinical Trials Browser

Phase 2 × Lymphoma, Mantle-Cell × parsaclisib × Clear all

NCT03235544 2025-03-18

(CITADEL-205)

Phase 2 Completed

162 enrolled 18 charts

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell